ArticleCancers2022

Longitudinal Humoral and Cellular Immune Responses Following SARS-CoV-2 Vaccination in Patients with Myeloid and Lymphoid Neoplasms Compared to a Reference Cohort: Results of a Prospective Trial of the East German Study Group for Hematology and Oncology (OSHO).

Sabrina Jotschke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.